KRONOS BIO, INC.

(KRON)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2020 2021 2022 2023 2024
Capitalization1 1 674766191--
Enterprise Value (EV)1 1 45860111820051,9
P/E ratio -5,50x-4,92x-1,18x-1,04x-0,81x
Yield -----
Capitalization / Revenue ----51,5x
EV / Revenue ----14,0x
EV / EBITDA -25,5x-4,02x-0,71x-0,92x-0,20x
Price to Book -----
Nbr of stocks (in thousands) 56 03456 34756 732--
Reference price (USD) 29,913,63,363,363,36
Announcement Date 03/23/202102/24/2022---
1 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales1 -----3,70
EBITDA1 --57,2-149-167-216-260
Operating profit (EBIT)1 -16,8-58,0-151-161-192-260
Operating Margin ------7 032%
Pre-Tax Profit (EBT)1 --88,4-151-160-192-260
Net income1 --88,4-151-155-186-228
Net margin ------6 170%
EPS2 -3,22-5,43-2,76-2,86-3,24-4,16
Dividend per Share ------
Announcement Date 07/31/202003/23/202102/24/2022---
1 USD in Million
2 USD
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4
Net sales1 ------
EBITDA ------
Operating profit (EBIT)1 -33,7-62,4-36,4-39,0-41,6-43,4
Operating Margin ------
Pre-Tax Profit (EBT)1 -33,6-62,3-36,3-37,7-39,0-40,9
Net income1 -33,6-62,3-36,3-37,9-40,5-44,4
Net margin ------
EPS2 -0,61-1,13-0,65-0,70-0,74-0,77
Dividend per Share ------
Announcement Date 11/09/202102/24/202205/04/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: December 2020 2021 2022 2023 2024
Net Debt1 ---9,26-
Net Cash position1 21616573,0-139
Leverage (Debt / EBITDA) 3,78x1,10x0,44x-0,04x0,53x
Free Cash Flow1 -47,5-122-147-193-241
ROE (Net Profit / Equities) -----
Shareholders' equity1 -----
ROA (Net Profit / Asset) -----
Assets1 -----
Book Value Per Share -----
Cash Flow per Share -----
Capex1 9,574,266,007,008,00
Capex / Sales ----216%
Announcement Date 03/23/202102/24/2022---
1 USD in Million
Estimates
Key data
Capitalization (USD) 190 620 195
Number of employees 96
Free-Float 85,5%
Free-Float capitalization (USD) 162 994 322
Avg. Exchange 20 sessions (USD) 2 367 889
Average Daily Capital Traded 1,24%
EPS & Dividend